BRITAIN'S COPYRIGHT MOVEMENT: INVESTIGATING PIONEERING BOUNDARIES WITH COPYRIGHT & CBG

The nation is seeing a burgeoning interest in copyright substances , particularly N,N-Dimethyltryptamine and this lesser-known cannabinoid. Investigators are increasingly examining the possibilities of these compounds for therapeutic purposes, prompting a nuanced dialogue around their regulatory